blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2544662

EP2544662 - FOAMABLE FORMULATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  26.03.2021
Database last updated on 14.06.2024
FormerThe patent has been granted
Status updated on  17.04.2020
FormerGrant of patent is intended
Status updated on  16.05.2019
FormerExamination is in progress
Status updated on  01.05.2019
FormerGrant of patent is intended
Status updated on  19.12.2018
FormerExamination is in progress
Status updated on  23.06.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
Nuvo Pharmaceuticals Inc.
7560 Airport Road, Unit 10
Mississauga, ON L4T 4H4 / CA
[2018/12]
Former [2013/03]For all designated states
Nuvo Research Inc.
7560 Airport Road, Unit 10
Mississauga, ON L4T 4H4 / CA
Inventor(s)01 / BUYUKTIMKIN, Servet
11772 Carmel Creek Road, 105
San Diego California 92130 / US
02 / BUYUKTIMKIN, Nadir
11772 Carmel Creek Road 105
San Diego California 92130 / US
03 / KISAK, Edward T.
3525 Bayside Lane Apt. B
San Diego California 92109 / US
04 / SINGH, Jagat
64 Grover Drive
Scarborough Ontario M1C 4V7 / CA
05 / NEWSAM, John M.
525 Westbourne Street
La Jolla California 92037-5449 / US
06 / KING-SMITH, Dominic
5814 Lord Cecil Street
San Diego California 92122 / US
07 / GALER, Bradley S.
1740 Lenape Road
Bldg. 2
West Chester Pennsylvania 19382 / US
 [2013/03]
Representative(s)Uexküll & Stolberg
Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstraße 4
22607 Hamburg / DE
[2020/21]
Former [2013/03]UEXKÜLL & STOLBERG
Patentanwälte
Beselerstrasse 4
22607 Hamburg / DE
Application number, filing date11713105.210.03.2011
[2020/21]
WO2011US28004
Priority number, dateUS20100312629P10.03.2010         Original published format: US 312629 P
[2013/03]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011112875
Date:15.09.2011
Language:EN
[2011/37]
Type: A2 Application without search report 
No.:EP2544662
Date:16.01.2013
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.2011 takes the place of the publication of the European patent application.
[2013/03]
Type: B1 Patent specification 
No.:EP2544662
Date:20.05.2020
Language:EN
[2020/21]
Search report(s)International search report - published on:EP10.05.2012
ClassificationIPC:A61K9/12, A61K47/20, A61K47/10, A61K31/196, A61K31/192, A61P19/02, A61K9/00, A61K31/10, A61K31/56
[2019/01]
CPC:
A61K9/122 (EP,US); A61K31/192 (EP,US); A61K31/196 (EP,US);
A61K31/56 (EP,US); A61K47/20 (EP,US); A61K9/0014 (EP,US);
A61P19/02 (EP); A61K31/10 (EP,US); A61K47/10 (EP,US) (-)
Former IPC [2013/03]A61K9/12, A61K47/20, A61K31/196, A61K31/192, A61P19/02
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/03]
Extension statesBA10.10.2012
ME10.10.2012
TitleGerman:SCHÄUMBARE FORMULIERUNG[2013/03]
English:FOAMABLE FORMULATION[2013/03]
French:FORMULATION EXPANSIBLE[2013/03]
Entry into regional phase10.10.2012National basic fee paid 
10.10.2012Designation fee(s) paid 
10.10.2012Examination fee paid 
Examination procedure10.10.2012Amendment by applicant (claims and/or description)
10.10.2012Examination requested  [2013/03]
11.12.2013Despatch of a communication from the examining division (Time limit: M04)
22.04.2014Reply to a communication from the examining division
10.12.2015Despatch of a communication from the examining division (Time limit: M06)
20.06.2016Reply to a communication from the examining division
13.06.2017Despatch of a communication from the examining division (Time limit: M06)
20.12.2017Reply to a communication from the examining division
04.07.2018Despatch of a communication from the examining division (Time limit: M02)
04.09.2018Reply to a communication from the examining division
20.12.2018Communication of intention to grant the patent
29.04.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
17.05.2019Communication of intention to grant the patent
07.11.2019Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time
12.12.2019Fee for grant paid
12.12.2019Fee for publishing/printing paid
12.12.2019Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.12.2013
Opposition(s)23.02.2021No opposition filed within time limit [2021/17]
Request for further processing for:The application is deemed to be withdrawn due to failure to fulfill actions required for granting the patent
12.12.2019Request for further processing filed
12.12.2019Full payment received (date of receipt of payment)
Request granted
17.04.2020Decision despatched
Fees paidRenewal fee
11.03.2013Renewal fee patent year 03
12.03.2014Renewal fee patent year 04
10.03.2015Renewal fee patent year 05
10.03.2016Renewal fee patent year 06
10.03.2017Renewal fee patent year 07
13.03.2018Renewal fee patent year 08
27.03.2019Renewal fee patent year 09
27.03.2020Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU10.03.2011
AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
MK20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
TR20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
[2024/29]
Former [2024/22]HU10.03.2011
AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
MK20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2023/27]HU10.03.2011
AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2023/24]AL20.05.2020
AT20.05.2020
CY20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/45]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
MC20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/24]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SI20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/10]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
PL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SK20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/09]AL20.05.2020
AT20.05.2020
CZ20.05.2020
DK20.05.2020
EE20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
IT20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/08]AL20.05.2020
DK20.05.2020
ES20.05.2020
FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RO20.05.2020
RS20.05.2020
SE20.05.2020
SM20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/04]AL20.05.2020
FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
NL20.05.2020
RS20.05.2020
SE20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2021/01]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
RS20.05.2020
SE20.05.2020
BG20.08.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/51]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
RS20.05.2020
SE20.05.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/50]FI20.05.2020
HR20.05.2020
LT20.05.2020
LV20.05.2020
SE20.05.2020
NO20.08.2020
GR21.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/48]FI20.05.2020
LT20.05.2020
SE20.05.2020
NO20.08.2020
IS20.09.2020
PT21.09.2020
Former [2020/47]LT20.05.2020
NO20.08.2020
IS20.09.2020
Former [2020/46]IS20.09.2020
Cited inInternational search[X]WO2008038147  (FOAMIX LTD [IL], et al) [X] 1,6-8 * paragraph [0217] * * claims 1,2,25,41,43 *;
 [X]WO2008032227  (BIOMAS LTD [IL], et al) [X] 1,4,5,60,63,64,108 * paragraphs [0011] , [0312] *;
 [XI]WO2008038140  (FOAMIX LTD [IL], et al) [X] 1,6-8 * paragraph [0119] * * claims 46-95 * * examples 1-9 * [I] 2,3,12,13,15-24,26-59,61,62,65-67,71,72,74-81,83-107;
 [XDPI]WO2010125470  (FOAMIX LTD [IL], et al) [XDP] 1-3,6,13,15-20,26-29,36,42,45-49,51-53,60-62,65-72,74-77,83-86,93,99,102-106,108 * examples 1-11 * [I] 4,5,7-12,14,21-25,30-35,37-41,43,44,50,54-59,63,64,73,78-82,87-92,94-98,100,101,107
ExaminationUS2007292359
 US4871767
by applicantWO2009090558
 WO2010125470
 US7651990
 US4478853
 EP0522624
 US5443369
 US2010320232
 WO2008133491
 US2009236371
 WO2008007943
 US7757899
 WO2006001445
 US6053364
 WO9713585
 US2008314931
 WO2007086731
 WO2009136781
 US2009212074
 WO2006112704
 US2009039110
 WO2006112701
 US7726518
 WO2006028121
 US7673854
 WO2004069418
 US7147133
 WO0242005
 US7735692
 WO2008045822
 US6547162
 WO9954054
 US2008300311
    - PILPEL N., "Foams in pharmacy", ENDEAVOUR, (1985), vol. 9, pages 87 - 91
    - "Foams", DURIAN, D. J., WEITZ, D. A., Kirk-Othmer Encyclo. Chem. Tech., (1994), vol. 11, pages 783 - 805
    - "Osteoarthritis", BOH L.E. ET AL., Phannacotherapy: a pathophysiological approach, APPLETON & LANGE, (1999), pages 1441 - 59
    - ROSENSTEIN, "Topical agents in the treatment of rheumatic disorders", RHEUM. DIS. CLIN NORTH AM., (1999), vol. 25, pages 899 - 918
    - JOURNAL OFPHARMACEUTICAL SCIENCES, (1971), vol. 60, pages 1175 - 1179
    - FRANZ, T. J., "Percutaneous absorption: on the relevance of in vitro data", J. INVEST. DERM., (1975), vol. 64, doi:doi:10.1111/1523-1747.ep12533356, pages 190 - 195, XP003002651

DOI:   http://dx.doi.org/10.1111/1523-1747.ep12533356
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.